Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement

• Egile Nagusiak: Kyu Yeon Hur (Egilea), Mee Kyoung Kim (Egilea), Seung Hyun Ko (Egilea), Miyeun Han (Egilea), Dong Won Lee (Egilea), Hyuk-Sang Kwon (Egilea), Committee of Clinical Practice Guidelines (Egilea), Korean Diabetes Association and Committee of the Cooperative Studies (Egilea), Korean Society of Nephrology (Egilea)
• Formatua: Liburua
• Argitaratua: The Korean Society of Nephrology, 2020-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The safety of metformin use for patients with type 2 diabetes mellitus (T2DM) and advanced kidney disease is controversial, and more recent guidelines have suggested that metformin be used cautiously in this group until more definitive evidence concerning its safety is available. The Korean Diabetes...